Is This the Top for Progenics Pharmaceuticals, Inc. (PGNX)? - Tale of the Tape


Shutterstock photo

Investors have definitely seen some solid trading in Progenics Pharmaceuticals, Inc. ( PGNX ) lately, leading to gains for some. However, PGNX is now in overbought territory thanks to its latest move, as the firm has an RSI value of 76.6. Additionally, Progenics Pharmaceuticals, Inc. currently has a Zacks Rank #4 (Sell), so if the earnings estimate trend is any guide, a fall might be coming for this overbought stock.

PROGENICS PHARM (PGNX): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by